Wednesday’s Highlights at Noon: Intercept Pharma (ICPT), LendingClub (LC), HP (HPQ), Nu Skin (NUS), Devon Energy (DVN)

By Carrie Williams

So far Wednesday, November 6, NASDAQ is down -2.01% and the S&P is down -0.52%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Intercept Pharma (ICPTResearch Report), LendingClub (LCResearch Report), HP (HPQResearch Report), Nu Skin (NUSResearch Report) and Devon Energy (DVNResearch Report).

Intercept Pharma is up 7.87% in midday trading to $80.27. Shares opened today at $74.41. The company has a 52-week low of $56.76 and a 52-week high of $131.87. On the Street’s front, the average 12-month analyst price target for the stock is $154.00, marking a 106.96% potential upside from current levels. In a report released today, Oppenheimer analyst Jay Olson maintained a Buy rating on ICPT, with a price target of $146.00, which represents a potential upside of 96% from where the stock is currently trading. Separately, on the same day, Stifel Nicolaus’ Derek Archila reiterated a Hold rating on the stock . Over the last 3 months, the insider sentiment on Intercept Pharma has been positive based on 100 corporate insider transactions. This sentiment is slightly higher than the average sector sentiment of insiders.

LendingClub is up 6.89% in midday trading to $15.05. Shares opened today at $14.08. The company has a 52-week low of $10.89 and a 52-week high of $19.18. On the Street’s front, the average 12-month analyst price target for the stock is $22.75, marking a 61.58% potential upside from current levels. In a report issued on October 14, BTIG analyst Giuliano Bologna maintained a Buy rating on LC, with a price target of $23.00, which implies an upside of 63% from current levels. Over the last 3 months, the insider sentiment on LendingClub has been neutral based on 75 corporate insider transactions. This sentiment is slightly lower than the average sector sentiment of insiders.

HP is down -6.7% in midday trading to $20.19. Shares opened today at $21.64. The company has a 52-week low of $15.93 and a 52-week high of $25.72. On the Street’s front, the average 12-month analyst price target for the stock is $18.70, marking a -13.59% potential downside from current levels. In a report issued on October 10, Goldman Sachs analyst Rod Hall downgraded HPQ to Sell, with a price target of $14.00, which represents a potential downside of 35% from where the stock is currently trading. Separately, on October 7, Argus’ Jim Kelleher downgraded the stock to Hold .

See today’s analyst top recommended stocks >>

Nu Skin is down -6.28% in midday trading to $39.37. Shares opened today at $42.01. The company has a 52-week low of $35.03 and a 52-week high of $73.12. On the Street’s front, the average 12-month analyst price target for the stock is $42.50, marking a 1.17% potential upside from current levels. In a report released today, Stifel Nicolaus analyst Mark Astrachan maintained a Hold rating on NUS, with a price target of $43.00, which represents a slight upside potential from current levels. Separately, on August 7, Citigroup’s Beth Kite maintained a Buy rating on the stock and has a price target of $49.00.

Devon Energy is down -6.12% in midday trading to $22.53. Shares opened today at $24.00. The company has a 52-week low of $19.72 and a 52-week high of $35.39. On the Street’s front, the average 12-month analyst price target for the stock is $33.17, marking a 38.21% potential upside from current levels. In a report issued on October 10, Seaport Global analyst Mike Kelly downgraded DVN to Hold. Separately, on September 23, Citigroup’s Brian Downey maintained a Buy rating on the stock and has a price target of $31.00.

See today’s analyst top recommended stocks >>

Trending Stocks Based on Insider Activity >>